Home › Categories › Law & Legal› IPR2018-01696

IPR2018-01696.pdf

🔗 Source: bigmoleculewatch.com

📊 Size: 1.84 MB

👤 Author: Fairbrother, Robyn

⬇️ Downloads: 93

Summary

Mylan Pharmaceuticals Inc. has filed a petition for inter partes review against Sanofi-Aventis Deutschland GmbH, challenging the validity of patent 9,526,844, which relates to a pen-type injector. The petition argues that claims 21-30 of the patent are obvious in light of prior art, including patents and applications by Møller, Steenfeldt-Jensen, and Klitgaard. Mylan asserts that the patent lacks written description support for claims 21-30 before May 2016 and that a person of ordinary skill in the art would have found the claimed invention obvious. The petition includes various exhibits, including expert declarations, patent documents, and file histories, to support its arguments.

Download File

Description

Mylan Pharmaceuticals Inc.

Technical Information

File Format: PDF
File Size: 1.84 MB
Pages: 82
Language: EN
Author: Fairbrother, Robyn
Total Downloads: 93
Last Updated: 1 week ago

Document Overview

This PDF document about IPR2018-01696 provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into IPR2018-01696.